ESC Professional Premium Access

An in vivo CRISPR base editing therapy to inactivate the ANGPTL3 gene: nomination of a development candidate for VERVE-201

Congress Presentation

About the speaker

Doctor Amit Khera

Verve Therapeutics, Boston (United States of America)
0 follower

5 more presentations in this session

Targeting RNA elongation in endothelial-to-mesenchymal transition

Speaker: Mr J. Hoba (Leipzig, DE)


Overexpression of miR-210 ameliorates endothelial dysfunction in type 2 diabetic mice

Speaker: Doctor A. Collado (Stockholm, SE)


Dicer prevents activation of the type I interferon pathway in lipid-loaded macrophages

Speaker: Mr N. Li (Munich, DE)


Diagnostic ability of miR-19a and Let-7f along with platelet and leukocyte extracellular vesicles in acute ischemic stroke patients

Speaker: Mrs C. Eyileten (Warsaw, PL)


Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome

Speaker: Miss M. Noormalal (Kiel, DE)


Access the full session

RNA and gene therapy of vascular diseases

Speakers: Doctor A. Khera, Mr J. Hoba, Doctor A. Collado, Mr N. Li, Mrs C. Eyileten...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb